Latest News

by Robert MacKay, Thursday, 19 January 2012 | Categories: Lorcaserin

Arena Pharmaceuticals must be very pleased with themselves since their application for weight loss treatment, Lorcaserin, was resubmitted and accepted by the Food and drug Administration in the US...




Researchers at the Welcome Trust- Mahosot Hospital-Oxford University Tropical Medicine Research Collaboration have published a worrying report in the Malaria Journal highlighting the fact that fraudulent anti-malarials will impact hugely on mortality rates over the next year if action is not taken s...




by Robert MacKay, Tuesday, 17 January 2012 | Categories: Slimming Pills

A team of researchers at Harvard Medical School claim they have created a pill that has the same effect on the body as exercise does without requiring us to move a muscle...




by Robert MacKay, Thursday, 12 January 2012 | Categories: Weight Loss

A recent study shows the benefit of treating overweight patients with glucagon-like peptide-1 receptor (GLP-1R) agonists, liraglutide and exenatide specifically, regardless of whether or not they have Type-2 diabetes...




by Robert MacKay, Tuesday, 10 January 2012 | Categories: Diet Pills

The Food and Drug Administration (FDA) in the US has given the all clear for phase I trials of Antipotide(a potential new anti-obesity drug), having approved Arrowhead Research Corporation’s Investigational New Drug Application...





 
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more Close